MEDANTA Share Price Performance
₹0
-1105.70 (-100.00%)
Price ₹0
Fair Value₹1,370.20
Share Pricen/a
Global Health (NSE:MEDANTA) Shareholders Will Want The ROCE Trajectory To Continue
Dec 07
Global Health Limited Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 14 Fair Values set on narratives written by author
MEDANTA Community Narratives
AN
Fair Value ₹1.37k 16.2% undervalued intrinsic discount
New Noida And Ranchi Hospitals Will Spark Lasting Healthcare Evolution
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
AN
Fair Value ₹1k 14.5% overvalued intrinsic discount
Excessive Hospital Expansion In India Will Heighten Risks
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value ₹1.54k 25.2% undervalued intrinsic discount
Digital Platforms And Aging Demographics Will Transform Premium Care
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
New Noida And Ranchi Hospitals Will Spark Lasting Healthcare Evolution
Key Takeaways Expansion into new regions and advanced specialty care boosts long-term revenue and diversifies income through premium services and international patient growth. Investments in technology, senior talent, and operational efficiency are expected to enhance profitability and support scalable, sustainable earnings.Read more
0users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
AN
₹1.37k
16.2% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
15.04% p.a.
Profit Margin
15.95%
Future PE
54.52x
Price in 2028
₹1.96k
Digital Platforms And Aging Demographics Will Transform Premium Care
Key Takeaways Rapid expansion into underserved regions and innovative technology adoption could drive faster-than-expected revenue growth and margin improvement. Strong brand presence in tier-2/3 cities, enhanced by strategic mergers and government partnerships, may accelerate patient inflow and free cash flow.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹1.54k
25.2% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
21.21% p.a.
Profit Margin
14.64%
Future PE
58.82x
Price in 2028
₹2.2k
Excessive Hospital Expansion In India Will Heighten Risks
Key Takeaways Heavy expansion and capital outlay bring significant execution and utilization risks, which could compress margins and returns if patient demand fails to meet expectations. Growing digital healthcare adoption, tightening regulations, and increased competition threaten traditional hospital models, exerting persistent pressure on revenue growth and profitability.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
₹1k
14.5% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
14.03% p.a.
Profit Margin
14.92%
Future PE
47.25x
Price in 2028
₹1.43k
Trending Discussion
Recently Updated Narratives
AN
MEDANTA: New Noida And Guwahati Hospitals Will Drive Long Term Upside
Fair Value: ₹1.37k 16.2% undervalued intrinsic discount
12 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Excessive Hospital Expansion In India Will Heighten Risks
Fair Value: ₹1k 14.5% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Digital Platforms And Aging Demographics Will Transform Premium Care
Fair Value: ₹1.54k 25.2% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Global Health Limited Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- 20.90
- 51.30%
- 14.03%
- 14.2%
About MEDANTA
- Founded
- 2004
- Employees
- 10260
- CEO
- WebsiteView website
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinion, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup. In addition, the company is involved in trading of pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
